Xwell (XWEL) Net Income towards Common Stockholders (2010 - 2026)
Xwell (XWEL) posted Net Income towards Common Stockholders of -$11.2 million for Q1 2026, up 39.36% sequentially from -$18.4 million in Q4 2025, and down 111.46% YoY from $97.5 million in Q1 2025.
Xwell (XWEL) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Xwell has reported Net Income towards Common Stockholders for 15 years, with the latest figure at -$11.2 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 111.46% year-over-year to -$11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$34.1 million (down 73.87% YoY) and the FY2025 annual result came in at -$28.2 million, down 67.53% from the prior year.
- Net Income towards Common Stockholders rose to -$11.2 million in Q1 2026 per XWEL's latest filing, from -$18.4 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$1.5 million in Q3 2025 and troughed at -$18.4 million in Q4 2025.
- A 5-year average of -$6.8 million and a median of -$5.5 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders sank 1588.95% in 2022, then soared 68.99% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$14.5 million in 2022, then surged by 66.35% to -$4.9 million in 2023, then slumped by 55.16% to -$7.6 million in 2024, then slumped by 142.7% to -$18.4 million in 2025, then jumped by 39.36% to -$11.2 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$11.2 million, -$18.4 million, and -$1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Xwell | 8.44 Mn | -3.33 Mn | 2.95 Mn | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.24 Mn |
| Mar 31, 2026 | -11.18 Mn |
| Dec 31, 2025 | -18.43 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -3.04 Mn |
| Mar 31, 2025 | -5.29 Mn |
| Dec 31, 2024 | -7.60 Mn |
| Sep 30, 2024 | -4.75 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -11.53 Mn |
| Jun 30, 2023 | -5.73 Mn |
| Mar 31, 2023 | -5.51 Mn |
| Dec 31, 2022 | -14.91 Mn |
| Sep 30, 2022 | -7.18 Mn |
| Jun 30, 2022 | -7.93 Mn |
| Mar 31, 2022 | -2.76 Mn |
| Dec 31, 2021 | 376,000.00 |
| Sep 30, 2021 | 5.60 Mn |